Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP for Melasma
NCT03674203Phase 2Completed
- Sponsor
- Instituto Mexicano del Seguro Social
- Start
- May 2017
- Primary completion
- May 2018
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of platelet-rich plasma in melasma, sponsored by Instituto Mexicano del Seguro Social. Primary endpoints: Melasma Area and Severity Index at 1 year, Histological analysis at 1 year and 4 more. Started May 2017; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
melasma
Beyond the preview
Go deeper on NCT03674203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03674203.